261 related articles for article (PubMed ID: 1331521)
1. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
[TBL] [Abstract][Full Text] [Related]
2. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
Holley-Guthrie EA; Quinlivan EB; Mar EC; Kenney S
J Virol; 1990 Aug; 64(8):3753-9. PubMed ID: 2164595
[TBL] [Abstract][Full Text] [Related]
4. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
Ragoczy T; Miller G
J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
[TBL] [Abstract][Full Text] [Related]
5. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
Zalani S; Holley-Guthrie E; Kenney S
J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
[TBL] [Abstract][Full Text] [Related]
6. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.
Zalani S; Coppage A; Holley-Guthrie E; Kenney S
J Virol; 1997 Apr; 71(4):3268-74. PubMed ID: 9060693
[TBL] [Abstract][Full Text] [Related]
7. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
Adamson AL; Kenney SC
Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
[TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
Kenney S; Holley-Guthrie E; Mar EC; Smith M
J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
[TBL] [Abstract][Full Text] [Related]
9. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
12. Pathways of activation of the Epstein-Barr virus productive cycle.
Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
Nonkwelo CB; Long WK
Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site.
Glaser G; Vogel M; Wolf H; Niller HH
Arch Virol; 1998; 143(10):1967-83. PubMed ID: 9856084
[TBL] [Abstract][Full Text] [Related]
15. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
[TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
Ragoczy T; Heston L; Miller G
J Virol; 1998 Oct; 72(10):7978-84. PubMed ID: 9733836
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
Sato H; Takeshita H; Furukawa M; Seiki M
J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
[TBL] [Abstract][Full Text] [Related]
19. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter.
Liu S; Borras AM; Liu P; Suske G; Speck SH
Virology; 1997 Feb; 228(1):11-8. PubMed ID: 9024805
[TBL] [Abstract][Full Text] [Related]
20. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
Zhang L; Chiu J; Lin JC
DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
